SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Destiny Tech100, Inc. operates as a non-diversified, closed-end management investment company. The company was founded on November 18, 2020 and is headquartered in Austin, TX.

Destiny Tech100 Inc

DESTINY TECH 100 INC

Destiny Tech100 is drawing significant attention from investors seeking exposure to high-growth private companies like SpaceX and Anthropic ahead of potential IPO activity. The community is actively debating the fund's portfolio concentration and its premium relative to net asset value, with many comparing it to other market participants as a strategic way to access unicorn investments.

Microsoft Corp. engages in the development and support of software, services, devices, and solutions. It operates through the following segments: Productivity and Business Processes, Intelligent Cloud, and More Personal Computing. The Productivity and Business Processes segment is composed of products and services relating to productivity, communication, and information services such as Office Commercial, Office Consumer, LinkedIn, and Dynamics business solutions. The Intelligent Cloud segment consists of public, private, and hybrid server products and cloud services for businesses and developers, as well as enterprise and partner services. The More Personal Computing segment refers to products and services including Windows operating system, Windows cloud services, Surface, HoloLens, personal computer accessories, Xbox hardware, Xbox Cloud Gaming, Microsoft News, and Microsoft Edge. The company was founded by Paul Gardner Allen and William Henry Gates, III in 1975 and is headquartered in Redmond, WA.

Microsoft Corporation

Microsoft Corp

Microsoft is facing significant selling pressure as investors grapple with AI-related capital expenditure concerns and broader software sector volatility. While the community remains deeply divided between long-term bulls highlighting strong fundamental cash flows and bears pointing to a technical breakdown, intense daily price fluctuations continue to fuel speculative debates over whether the stock is a value trap or a generational buying opportunity.

The Shrimp Army

SHRIMPS is gaining momentum as part of a broader trend of ocean-themed memecoins, sparking intense community debate over its potential for rapid gains versus the risks of typical pump-and-dump volatility. Traders are actively comparing it to other ecosystem tokens while discussing strategies to capture momentum and eliminate zeros in the coin's price.

NKN is building the largest blockchain for network sharing.

New Kind of Network

NKN is capturing significant community attention as a potential DePIN and Web3 breakout candidate, fueled by its low market cap and the promise of its secure, decentralized nMobile communications platform. Traders are actively debating whether the asset is currently experiencing manipulative price suppression or coiling for a major move as they compare its utility and scarcity against other high-growth altcoins.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is trending as investors grapple with the launch of a private-label energy drink by Costco, sparking intense community debate over potential market share loss and brand loyalty. While some traders are reacting to the negative sentiment and bearish price action, many long-term shareholders view the pullback as a buying opportunity, emphasizing that the company's core growth, international expansion, and strong brand presence remain intact despite the noise.

Zillow Group, Inc. engages in the provision of real estate and home-related information marketplaces on mobile and the web. The company was founded by Richard N. Barton and Lloyd D. Frink in December 2004 and is headquartered in Seattle, WA.

Zillow Group Inc - Ordinary Shares - Class C

Zillow Group Inc Class C

Zillow is currently a focal point for community debate, as users weigh the impact of recent housing market data and shifting mortgage rate expectations against the platform's role in the evolving digital real estate landscape. Traders are actively monitoring potential integration opportunities and sector-wide sentiment, with much of the discussion centered on how Zillow stacks up against emerging competitors and broader housing sector challenges.

XRP is a decentralized digital asset and the native token of the XRP Ledger, a Layer 1 blockchain designed for high-performance global payments. Its primary value proposition is offering a fast, cost-effective alternative to traditional banking systems by enabling near-instant cross-border settlements that finalize in three to five seconds. By serving as a neutral bridge asset between different fiat currencies, it helps financial institutions lower liquidity costs and eliminates the need for pre-funded accounts.  The network is unique because it utilizes a federated consensus protocol instead of energy-intensive mining or staking. This system achieves deterministic finality through a Unique Node List of trusted validators who must reach an eighty percent agreement threshold to permanently record transactions. This infrastructure supports a sustained throughput of 1,500 transactions per second and includes a built-in decentralized exchange that allows for the automated trading of any tokenized asset without intermediaries.  The project traces its origins back to 2004 with Ryan Fugger before being co-founded in its modern form by Jed McCaleb and Chris Larsen. The company, now known as Ripple, works with major financial institutions as partners and investors to build global payment solutions. To protect the network from spam, a small amount of XRP is burned during every transaction, and the token is further utilized by institutions as collateral to access traditional markets and manage digital asset infrastructure.  Institutional adoption of the asset reached a major milestone in November 2025 when the SEC approved the first wave of spot XRP ETFs. These products, offered by major issuers including Bitwise, Grayscale, 21Shares, Canary Capital, and Franklin Templeton, are now listed on prominent exchanges like the NYSE Arca, Nasdaq, and Cboe BZX. While Ripple remains a key contributor to the ecosystem, the underlying XRP Ledger continues to operate as an open-source and decentralized network.

Ripple

The Ripple community is actively debating the impact of the pending Clarity Act on XRP's price, with many users speculating on its potential to drive institutional adoption and long-term valuation shifts. Discussions are heavily fueled by a mix of market skepticism, frustration over current price consolidation, and excitement surrounding upcoming legislative hearings on tokenization.

Strategy, Inc. engages in the provision of enterprise analytics and mobility software. The firm designs, develops, markets, and sells software platforms through licensing arrangements and cloud-based subscriptions and related services. Its product packages include Hyper. The company was founded by Michael J. Saylor and Sanjeev K. Bansal on November 17, 1989, and is headquartered in Tysons Corner, VA.

Strategy Inc. - Ordinary Shares - Class A

Strategy

MicroStrategy is generating intense debate as traders weigh aggressive corporate Bitcoin accumulation against concerns regarding share dilution and the stock's high premium. While bulls highlight the company's massive digital asset reserves as a long-term lever, bears are actively targeting the symbol's volatility and its status as a high-beta proxy for broader crypto market swings.

Karyopharm Therapeutics, Inc. is a commercial-stage pharmaceutical company, which engages in the discovery, development, and commercialization of drugs directed against nuclear export for the treatment of cancer and other diseases. The company was founded by Joseph Araujo, Ronald A. DePinho, Pamela A, Silver, Giulio Draetta, Michael G. Kauffman, and Sharon Shacham on December 22, 2008, and is headquartered in Newton, MA.

Karyopharm Therapeutics Inc

Karyopharm Therapeutics is trending as investors weigh recent strategic financing moves, which have extended the company's cash runway through early 2026, against significant concerns regarding long-term management performance and potential dilution. The community remains deeply divided, with some pointing to the upcoming phase 3 myelofibrosis data as a high-risk, high-reward turning point, while vocal shareholders continue to express frustration over the stock's long-term depreciation and leadership's capital allocation strategies.

Alphabet, Inc. is a holding company, which engages in software, health care, transportation, and other technologies. It operates through the following segments: Google Services, Google Cloud, and Other Bets. The Google Services segment includes products and services, such as ads, Android, Chrome, devices, Google Maps, Google Play, Search, and YouTube. The Google Cloud segment refers to infrastructure and platform services, collaboration tools, and other services for enterprise customers. The Other Bets segment relates to the sale of healthcare-related services and internet services. The company was founded by Lawrence E. Page and Sergey Mikhaylovich Brin on October 2, 2015 and is headquartered in Mountain View, CA.

Alphabet Inc - Ordinary Shares - Class C

Alphabet is facing scrutiny and volatility as investors weigh the company's aggressive infrastructure investment in AI against broader macroeconomic concerns, including rising energy costs and geopolitical instability. While some in the community see the current price as a buying opportunity for a long-term compounder, others remain cautious, pointing to ongoing regulatory challenges and concerns over whether recent AI spending will generate sufficient near-term returns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Artiva Biotherapeutics (ARTV) Expected to Announce Earnings on Monday

Artiva Biotherapeutics (NASDAQ:ARTV) will be releasing its Q4 2025 earnings before the market opens on Monday, March 30. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-3-30-artiva-biotherapeutics-inc-stock...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decrease in Short Interest

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) was the target of a large decrease in short interest in the month of February. As of February 27th, there was short interest totaling...

Research Analysts Issue Forecasts for ARTV Q1 Earnings

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Free Report) - Investment analysts at HC Wainwright upped their Q1 2026 earnings per share estimates for shares of Artiva Biotherapeutics in a report...

Artiva Biotherapeutics' (ARTV) Buy Rating Reiterated at Needham & Company LLC

Needham & Company LLC reiterated a "buy" rating and issued a $18.00 price target on shares of Artiva Biotherapeutics in a research note on Wednesday...

Artiva Biotherapeutics Pivots to Rheumatoid Arthritis at TD Cowen, Teases 2026 RA Data Update

Artiva Biotherapeutics (NASDAQ:ARTV) used a presentation and fireside chat at TD Cowen's 46th Annual Healthcare Conference to outline its strategy in deep B-cell depletion for autoimmune disease...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Given Average Recommendation of "Moderate Buy" by Analysts

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) has received an average recommendation of "Moderate Buy" from the six brokerages that are covering the stock, MarketBeat.com reports. One...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Short Interest Down 28.5% in January

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) was the recipient of a large decrease in short interest in January. As of January 30th, there was short interest totaling 203,792 shares...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Receives Consensus Rating of "Moderate Buy" from Brokerages

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) has been given a consensus rating of "Moderate Buy" by the six analysts that are presently covering the stock, Marketbeat.com reports. One...

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV) Sees Significant Decline in Short Interest

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Get Free Report) saw a large drop in short interest in January. As of January 15th, there was short interest totaling 284,944 shares, a drop of 27.1% from...

Brokers Set Expectations for ARTV FY2030 Earnings

Artiva Biotherapeutics, Inc. (NASDAQ:ARTV - Free Report) - Analysts at HC Wainwright issued their FY2030 earnings per share estimates for shares of Artiva Biotherapeutics in a research report issued...

$ARTV Q4 &#39;25 Earnings Results &amp; Recap

Artiva Biotherapeutics expects existing cash, cash equivalents, and investments of $108M to fund planned operating expenses and capital expenditure requirements into the second quarter of 2027.

Stocktwits

Artiva Biotherapeutics Inc

 Q4 '25 Earnings Results & Recap

Artiva Biotherapeutics expects existing cash, cash equivalents, and investments of $108M to fund planned operating expenses and capital expenditure requirements into the second quarter of 2027.

This account has been verified as an official STOCKTWITS representative.

Verified Account

Stocktwits Earnings

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

ARTV
Artiva Biotherapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Earnings Recap

Latest ARTV News

ARTVArtiva Biotherapeutics Inc